Table 1.
Demographic and clinical characteristics of all study patients.
Table 2.
Correlations between aspartate aminotransferase (AST), alanine aminotransferase (ALT) serum levels and FIB-4 score with various metabolic markers in 105 study patients.
Spearman correlation coefficients (p-value) are presented for each marker and significant p- values are shown in BOLD font.
Table 3.
a. Factors associated with Fibroscan result ≥7.2 kPa. Logistic regression analysis in all study patients (n = 105). b. Multi-variable analysis of factors associated with Fibroscan result ≥7.2 kPa.
Fig 1.
Receiver-operating characteristic (ROC) curves showing area under the curve (AUC) for 105 patients.
The outcome of NAFLD severity (defined by Fibroscan score ≥7.2 kPa) is tested against NAFLD fibrosis index (NIFI), NAFLD fibrosis score (NFS) and FIB-4 score.